Roy
Analyst
UBS
Equibles does not estimate personal net worth.
About Roy
Roy is recorded as Analyst at UBS. Roy has spoken on 1 earnings call across 1 company, most recently for SAB Biotherapeutics, Inc. on August 6, 2026. The companies whose calls Roy spoke on are classified in the Healthcare sector.
Roy on recent calls
“As it pertains to the data from Safeguard and then PRIZE, could you maybe talk a little bit about the rationale behind the labeling strategy here and also the planned sequencing and timing of the filings?”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current